Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses
about
Biological mimicry of antigenic stimulation: analysis of the in vivo antibody responses induced by monoclonal anti-idiotypic antibodiesFactors contributing to the immunogenicity of meningococcal conjugate vaccinesThe nature and combination of subunits used in epitope-based Schistosoma japonicum vaccine formulations affect their efficacy.Reduced response to multiple vaccines sharing common protein epitopes that are administered simultaneously to infants.Carrier properties of a protein derived from outer membrane protein A of Klebsiella pneumoniae.Targeting of nasal mucosa-associated antigen-presenting cells in vivo with an outer membrane protein A derived from Klebsiella pneumoniae.Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.Carbohydrate antigen delivery by water soluble copolymers as potential anti-cancer vaccines.A dual vaccine against influenza & Alzheimer's disease failed to enhance anti-β-amyloid antibody responses in mice with pre-existing virus specific memory.Influence of preimmunization with tetanus toxoid on immune responses to tetanus toxin fragment C-guest antigen fusions in a Salmonella vaccine carrier.Lipopeptide-Coated Iron Oxide Nanoparticles as Potential Glycoconjugate-Based Synthetic Anticancer Vaccines.Strategies to alleviate original antigenic sin responses to influenza viruses.Epitope-specific regulation. II. A bistable, Igh-restricted regulatory mechanism central to immunologic memoryA first or dominant immunization. I. Suppression of simultaneous cytolytic T cell responses to unrelated alloantigensImmunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopesA Fully Synthetic Self-Adjuvanting Globo H-Based Vaccine Elicited Strong T Cell-Mediated Antitumor Immunity.Effect of carrier priming on immunogenicity of saccharide-protein conjugate vaccinesBoosting immunity to small tumor-associated carbohydrates with bacteriophage qβ capsids.Reduction of antibody response to an 11-valent pneumococcal vaccine coadministered with a vaccine containing acellular pertussis components.Adjuvants.Cyclopeptide scaffolds in carbohydrate-based synthetic vaccines.Visualization of negative signaling in B cells by quantitative confocal microscopy.Identification of B- and T-cell epitopes of BB, a carrier protein derived from the G protein of Streptococcus strain G148.The effect of preexisting anti-carrier immunity on subsequent responses to CRM197 or Qb-VLP conjugate vaccines.Lyb3: a B cell surface antigen associated with triggering secretory differentiation.Incorporation of T and B epitopes of the circumsporozoite protein in a chemically defined synthetic vaccine against malariaVirus like particles as a platform for cancer vaccine development.Selection of carrier and B cell protectope sequences for vaccines.Epitope-specific regulation of memory B-cell expression.
P2860
Q28361383-780A8A35-9573-414C-A44F-29DDA81229A7Q28828544-F310D984-9F71-4EEA-8730-0C111199830CQ30502461-FDA9A2AC-0FC6-4DC8-80C5-2C41315AA000Q33753799-E929E6ED-3981-4186-AA70-F6B90400C593Q34002277-C2491E8F-B36F-4AC8-BC3D-EC39B917CD2EQ34009439-BF2E6B5E-5F72-414E-A7B1-C92E16A08987Q34235531-AF66A6EC-5C8F-4D23-8A74-E7F597AE7C06Q34478719-811F3B43-8D8E-4DD4-AD91-B97458482494Q35040016-FF434B0C-7790-4ECF-93C7-579B45DDEF08Q35422555-FB8FE8EB-0645-402B-8964-8F2ECB9B40C3Q35705462-05EA0D79-9327-4D12-A0EF-D984D40236E5Q36187304-F1CD726D-C76C-489E-852E-538F6DB91A81Q36346585-57B83269-5605-4A84-B942-A3F21C3FC508Q36362238-3FEEA7AF-DA06-4D73-B3FF-93F1553A0FECQ36363602-4F0FE82F-3974-4574-BAA8-FCB153503EE8Q36604334-B3341E80-66EE-4A00-8584-690A668A2F82Q36987808-D19CD6A4-802D-43DA-AF73-B5C33A6B5513Q37076109-27B33CCD-6C13-489C-BD66-0A963A1D4BB4Q37521333-9460AC3D-E8EC-47CD-9A5C-EE154E9E686CQ37844069-4E2FFAC2-8B87-4123-A96C-5DA9487F84F9Q39169715-121A0EC1-84BC-41C2-9783-BF2B0FB43E21Q39529295-33E76D70-3C06-4577-A98D-E1CCD39BB38BQ39714037-1186937F-54B0-4305-86C7-B504124C2085Q39816694-F6C71AEA-EFAD-459E-9E8E-58F104C53687Q40114065-C1E71734-879B-48DC-9641-7E0C0040E96EQ41825440-25C6ED79-EC8B-41D0-B0B9-B4D4EC7FFAFCQ45324534-BFA82357-E363-4BC8-9208-ED97FEAFDED7Q48001511-C72FA13C-AD9A-4FE0-BAB4-391C7E4EBDEEQ52223490-F82A726B-E71F-4C12-AEEB-F9A466814CD5
P2860
Epitope-specific regulation. I. Carrier-specific induction of suppression for IgG anti-hapten antibody responses
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年学术文章
@wuu
1982年学术文章
@zh-cn
1982年学术文章
@zh-hans
1982年学术文章
@zh-my
1982年学术文章
@zh-sg
1982年學術文章
@yue
1982年學術文章
@zh
1982年學術文章
@zh-hant
name
Epitope-specific regulation. I ...... anti-hapten antibody responses
@ast
Epitope-specific regulation. I ...... anti-hapten antibody responses
@en
type
label
Epitope-specific regulation. I ...... anti-hapten antibody responses
@ast
Epitope-specific regulation. I ...... anti-hapten antibody responses
@en
prefLabel
Epitope-specific regulation. I ...... anti-hapten antibody responses
@ast
Epitope-specific regulation. I ...... anti-hapten antibody responses
@en
P2860
P356
P1476
Epitope-specific regulation. I ...... anti-hapten antibody responses
@en
P2093
L A Herzenberg
T Tokuhisa
P2860
P304
P356
10.1084/JEM.155.6.1730
P407
P577
1982-06-01T00:00:00Z